Stadium Capital funds sell Sleep Number shares
Sleep Number Corp disclosed that investment funds associated with Stadium Capital completed open-market sales of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sleep Number Corp disclosed that investment funds associated with Stadium Capital completed open-market sales of Common Stock. Stadium Special Opportunity I, L.P. sold 59,944 shares at a weighted average price of $1.7791 per share and now holds 341,515 shares indirectly. Stadium Capital Partners, L.P. sold 330,732 shares at the same weighted average price and now holds 1,884,268 shares indirectly. The reporting group states these trades were executed across multiple prices between $1.6800 and $1.8750 per share and disclaims beneficial ownership beyond its pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.01 per share | 330,732 | $1.7791 | $588K |
| Sale | Common Stock, par value $0.01 per share | 59,944 | $1.7791 | $107K |
Footnotes (4)
- F1. This Form 4 is filed jointly by Stadium Capital Management, LLC ("SCM"), Stadium Capital Management GP, L.P. ("SCMGP"), Stadium Special Opportunity I, L.P. ("SSO"), Stadium Capital Partners, L.P. ("SCP") and Alexander M. Seaver (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of Sleep Number Corporation's (the "Issuer") outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.6800 to $1.8750 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. Securities owned directly by SCP. As the general partner of SCP, SCMGP may be deemed to beneficially own the securities owned directly by SCP. SCM, as the investment advisor of SCP and general partner of SCMGP, may be deemed to beneficially own the securities owned directly by SCP. Mr. Seaver, as the manager of SCM, may be deemed to beneficially own the securities owned directly by SCP.
- F4. Securities owned directly by SSO. As the general partner of SSO, SCMGP may be deemed to beneficially own the securities owned directly by SSO. SCM, as the investment advisor of SSO and general partner of SCMGP, may be deemed to beneficially own the securities owned directly by SSO. Mr. Seaver, as the manager of SCM, may be deemed to beneficially own the securities owned directly by SSO.
Key Figures
Key Terms
Section 13(d) group regulatory
weighted average price financial
beneficial ownership regulatory
pecuniary interest financial
ten percent owner regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider sales did Stadium Capital report in Sleep Number (SNBR)?
What are Stadium Capital’s remaining Sleep Number (SNBR) holdings after these sales?
How does the Form 4 describe Stadium Capital’s beneficial ownership in SNBR?
What pricing details are disclosed for the Sleep Number (SNBR) insider sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.